Pluristem Therapeutics Inc (PSTI)

[HappyBee]

Thank you for providing a link and translation from Google Translate for the article, PLX-11.

I don't speak Hebrew, but something must have got lost in translation. The translated version of the article appears to contradict the information from the news release.

Article.

"Pluristem was unable (Able?) to show statistical significance at the primary trial target, which was an improvement in the maximal walking distance of patients who received two injections of 300 million PLX-PAD cells compared to patients who received placebo after 52 weeks."

News Release.

"Patients treated with 2 administrations of 300 million PLX-PAD cells showed statistically significant improvement (p=0.0008) in MWD as compared to baseline at 52 weeks."

The reference to endometriosis surely must be wrong.

"The cost of treatment for the American health system in severe endometriosis is estimated at $ 50,000 per patient per year and the total cost of $ 10 billion is the same as in Europe."

HappyBee

PS I do agree with your investment strategy (your earlier post). Regardless of the share price the recent clinical data is a ray of sunshine.